Johannes Wrege1, André Schmidt1, Anna Walter1, Renata Smieskova1, Kerstin Bendfeldt2, Ernst-Wilhelm Radue2, Undine E. Lang1 and Stefan Borgwardt1,2
Cannabis sativa is a widely used drug comprising a broad spec- trum of usage ranging from recreational users to chronic addicts [1, 2]. Over the last years, accumulating evidence revealed that canna- bis use leads to structural and functional brain abnormalities in cannabis users [3, 4]. For example, neuroimaging data showed that cannabis use reduced grey and white matter volumes in cannabi- noid-receptor rich areas, as well as changed functional activity in the prefrontal and anterior cingulate cortex .
acesse: Borgwardt-db-JW_SB cpia 2.pdf